Sales rise 30.16% to Rs 507.98 crore
Net profit of Glenmark Pharmaceuticals rose 114.85% to Rs 117.80 crore in the quarter ended June 2013 as against Rs 54.83 crore during the previous quarter ended June 2012. Sales rose 30.16% to Rs 507.98 crore in the quarter ended June 2013 as against Rs 390.28 crore during the previous quarter ended June 2012. ParticularsQuarter EndedJun. 2013Jun. 2012% Var.Sales507.98390.28 30 OPM %25.8716.82 -PBDT144.2567.15 115 PBT137.5861.08 125 NP117.8054.83 115Powered by Capital Market - Live News